November 03-04, 2025
Prague, Czech Republic

2nd European Hematology and Blood Disorders Congress

Theme : Advancing Frontiers in Hematology and Blood Research

About Hematology Congress

Welcome to the 2nd European Hematology and Blood Disorders Congress, scheduled for November 03-04, 2025, in Prague, Czech Republic. This prestigious congress bring together hematologists, oncologists, researchers, clinicians, and healthcare professionals from around the globe to delve into the latest advancements in hematology and blood disorders.

Attendees can expect a comprehensive program featuring keynote presentations, interactive workshops, poster sessions, and panel discussion covering hematologic disorders, transfusion medicine, stem cell transplantation, immunotherapy, and precision medicine in hematology.

The congress serves as a vital platform for knowledge exchange, networking, and collaboration among expert and stakeholders in the field. Participants will have the opportunity to explore innovative therapies, discuss emerging research findings, and address challenges in hematology practice and patient care.

Join us in Prague to contribute to advancements in hematology and blood disorders, forging connections that drive progress and improve outcomes for patients worldwide.

Sessions

Hematology and Blood Disorders
Hematology-Oncology
Hemoglobinopathies
Hemostasis and Thrombosis
Anemia & Clinical Hematology
Biomarkers in Hematologic Diseases
Blood Disorders Types, Diagnosis and Treatment
Emerging Technologies in Hematology
Genetic and Molecular Basis of Blood Disorders
Pharmacology of Chemotherapy
Acute and Chronic Lymphocytic Leukemia
Advanced Treatment and Research in Hematology
Bone Marrow & Cord Blood Transplantation
Epidemiology and Public Health in Hematology
Gene Editing, Cell and Gene Therapy in Hematology
Hematology and Covid-19
Hematology Nursing
Hemoglobin and Iron Metabolism
Immunohematology
Neuro-Hematology
Myelodysplastic and Myeloproliferative Disorders
Leukemia and Blood Cancers
Pediatric Hematology
Transfusion Medicine
Submit Your Abstract

Track Your Abstract

Important Dates

Abstract Submission Deadline: May 28, 2025

Early Bird Registration: May 30, 2025

Mid Term Registration: Aug 29, 2025

Final/Onsite Registration: Nov 02, 2025

International Organizing Committee

Josef Prchal

The Charles A. Nugent & Margaret Nugent Endowed Professor, University of Utah & Huntsman Cancer Center

USA

Drew Provan

Emeritus Reader in Autoimmune Haematology, Barts & The London School of Medicine

United Kingdom

Kerri L. Norris

Senior Vice President, Health Access and Stategic Innovation

USA

Previous Speakers

Alejandro Covalin

Spark Biomedical Inc

USA

Mariachiara Gagliardi

AORN Moscati

Italy

Ingrid Brezaniova

West Medica Produktions- und Handels- GmbH

Austria

Livia Bernardi

Annunziata Hospital

Italy

Why Attend Conference
  • Gain insights into the latest research, treatments, and innovations in hematology and blood disorders.
  • Connect with leading hematologists, oncologists, researchers, and healthcare professionals from around the world.
  • Stay updated with evolving guidelines, clinical trials, and best practices in the field of hematology.
  • Learn about cutting-edge technologies & therapies shaping the future of hematology & blood disorder treatments.
  • Gain practical insights and strategies to improve patient outcomes and quality of care in hematology.
Learning

Gain insights and skills through presentations, workshops, and discussions on cutting-edge research and trends.

Networking

Connect with peers, experts, and collaborators to expand your professional network.

Perspectives

Explore diverse viewpoints and cultural insights, discovering new approaches and trends in your field.

Where to find us

Venue & Info

Event Venue

Prague, Czech Republic

Location Address
Prague, Czech Republic
Past Conference Report

Hematology Congress Rome

C2P Forum is pleased to announce the successful completion of the European Hematology and Blood Disorders Congress, held on April 14-15, 2025, in Rome, Italy.

The conference, themed “Exploring Innovations in Blood Transfusion and Emerging Concepts in Hematology” concluded with great success.

We extend our sincere gratitude to the esteemed scientists, distinguished researchers, students and professionals from universities, research institutions, companies, and laboratories worldwide who contributed their latest insights and expertise in the field of Hematology and Blood Disorders.

The conference featured a dynamic program, including keynote addresses, oral presentations, poster sessions, and video presentations. The event was marked by significant engagement and outstanding contributions, and we are delighted to share some of the key highlights presented during the sessions:

  • Thomas Licht, Ludwig Boltzmann for Rehabilitation Research, Austria
  • Alexander A. Mironov, The AIRC Institute of Molecular Oncology, Italy
  • Stuart S. Martin, University of Maryland School of Medicine, USA
  • Petar Ozretić, Ruđer Bošković Institute, Croatia
  • Alejandro Covalin, Spark Biomedical Inc, USA
  • Anna E. Marneth, Radboud University Medical Center, The Netherlands
  • Clara Madrid-Alejos, Catalan Institute of Oncology (ICO), Spain
  • Mariachiara Gagliardi, AORN Moscati, Italy
  • Ingrid Brezaniova, West Medica Produktions-und Handels- GmbH, Austria
  • Min-Sik Lee, Pohang University of Science and Technology (POSTECH), South Korea
  • Gaurav Vishal, Prathima Cancer Institute, India
  • Bufan Zhang, Tianjin Medical University General Hospital, China
  • Lili Hou, Shanghai Jiao Tong University School of Medicine, China
  • Livia Bernardi, Annunziata Hospital, Italy
  • Tahereh Safari, Arta Nano Biophysics Company, Iran
  • Thomas Licht, Ludwig Boltzmann for Rehabilitation Research, Austria
  • Alexander A. Mironov, The AIRC Institute of Molecular Oncology, Italy
  • Stuart S. Martin, University of Maryland School of Medicine, USA
  • Petar Ozretić, Ruđer Bošković Institute, Croatia
  • Alejandro Covalin, Spark Biomedical Inc, USA
  • Anna E. Marneth, Radboud University Medical Center, The Netherlands
  • Clara Madrid-Alejos, Catalan Institute of Oncology (ICO), Spain
  • Mariachiara Gagliardi, AORN Moscati, Italy
  • Ingrid Brezaniova, West Medica Produktions-und Handels- GmbH, Austria
  • Min-Sik Lee, Pohang University of Science and Technology (POSTECH), South Korea
  • Gaurav Vishal, Prathima Cancer Institute, India
  • Bufan Zhang, Tianjin Medical University General Hospital, China
  • Lili Hou, Shanghai Jiao Tong University School of Medicine, China
  • Livia Bernardi, Annunziata Hospital, Italy
  • Tahereh Safari, Arta Nano Biophysics Company, Iran

We would like to express our sincere appreciation to our Session Chairs Alexander A. Mironov, The AIRC Institute of Molecular Oncology, Italy for their valuable contributions and for skilfully guiding the conference sessions.

Building on the success of the Hematology Congress Rome , we are pleased to announce our upcoming event, 2nd European Hematology and Blood Disorders Congress, held on November 03-04, 2025 in Prague, Czech Republic.

More info: https://hematology.c2pforum.com/

Huge thanks to all the delegates! Your energy and involvement made this event a big success!

Mark your calendars and set your reminders.

Hope to meet you again in Prague, Czech Republic!!

"
"